Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yuanyuan Li, Ying Zhang, Jinxia Zhao, Jialu Bian, Yinyu Zhao, Xu Hao, Boyu Liu, Lei Hu, Fang Liu, Changqing Yang, Yufei Feng & Lin Huang. (2023) Combined impact of hypoalbuminemia and pharmacogenomic variants on voriconazole trough concentration: data from a real-life clinical setting in the Chinese population. Journal of Chemotherapy 0:0, pages 1-11.
Read now
Read now
Xingxian Luo, Taifeng Li, Lei Hu, Silu Liu, Haiyan Zhao, Jiaqi Zhang, Yufei Feng & Lin Huang. (2021) Differential effects of C-reactive protein levels on voriconazole metabolism at three age groups in allogeneic hematopoietic cell transplant recipients. Journal of Chemotherapy 33:2, pages 95-105.
Read now
Read now
Articles from other publishers (9)
Xu Hao, Yuanyuan Li, Ying Zhang, Jialu Bian, Jinxia Zhao, Yinyu Zhao, Lei Hu, Xingxian Luo, Changqing Yang, Yufei Feng & Lin Huang. (2023) Individualized treatment with voriconazole in the Chinese population: Inflammation level as a novel marker for dose optimization. British Journal of Clinical Pharmacology.
Crossref
Crossref
Lin Cheng, Yue Zhao, Zaiming Liang, Xi You, Changsheng Jia, Xiuying Liu, Qian Wang & Fengjun Sun. (2023) Prediction of plasma trough concentration of voriconazole in adult patients using machine learning. European Journal of Pharmaceutical Sciences 188, pages 106506.
Crossref
Crossref
Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, Rosanne Sprute, Annika Y Classen, Sonja E Zapke, Martin Hoenigl, Robert Krause, Martin Schmidt-Hieber, Werner J Heinz, Michael Klein, Philipp Koehler, Blasius Liss, Michael Koldehoff, Christoph Buhl, Olaf Penack, Georg Maschmeyer, Enrico Schalk, Cornelia Lass-Flörl, Meinolf Karthaus, Markus Ruhnke, Oliver A Cornely & Daniel Teschner. (2023) Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Journal of Antimicrobial Chemotherapy 78:8, pages 1813-1826.
Crossref
Crossref
Yun Wu, Chunle Lv, Dongni Wu, Jianying Qi, Rongda Cai, Siru Zhou, Chengxin Li, Yinyi Wei & Taotao Liu. (2022) Dosage optimization of voriconazole in children with haematological malignancies based on population pharmacokinetics. Journal of Clinical Pharmacy and Therapeutics 47:12, pages 2245-2254.
Crossref
Crossref
Chunyan Chen, Tao Xu, Keting Zhou & Suyan Zhu. (2022) Factors affecting voriconazole concentration to dose ratio changes according to route of administration. European Journal of Hospital Pharmacy, pages ejhpharm-2021-003173.
Crossref
Crossref
Benjamin KablyManon LaunayAudrey DerobertmasureSandrine Lefeuvre, Eric DannaouiEliane M. Billaud. (2022) Antifungal Drugs TDM: Trends and Update. Therapeutic Drug Monitoring 44:1, pages 166-197.
Crossref
Crossref
Yi-Chang Zhao, Yang Zou, Jing-Jing Hou, Chen-Lin Xiao, Bi-Kui Zhang, Jia-Kai Li, Da-Xiong Xiang, Indy Sandaradura & Miao Yan. (2021) Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children. Antibiotics 10:12, pages 1542.
Crossref
Crossref
Yichang Zhao, Chenlin Xiao, Jingjing Hou, Jiamin Wu, Yiwen Xiao, Bikui Zhang, Indy Sandaradura & Miao Yan. (2021) A Large Sample Retrospective Study on the Distinction of Voriconazole Concentration in Asian Patients from Different Clinical Departments. Pharmaceuticals 14:12, pages 1239.
Crossref
Crossref
Indy Sandaradura, Jessica Wojciechowski, Deborah J. E. Marriott, Richard O. Day, Sophie Stocker & Stephanie E. Reuter. (2021) Model-Optimized Fluconazole Dose Selection for Critically Ill Patients Improves Early Pharmacodynamic Target Attainment without the Need for Therapeutic Drug Monitoring. Antimicrobial Agents and Chemotherapy 65:3.
Crossref
Crossref